Dialysis News and Research

Latest Dialysis News and Research

Cancer Institute of New Jersey expands hospital network

Enhancing its strong presence as a statewide leader in cancer care and providing patients with additional access to cancer programs, The Cancer Institute of New Jersey (CINJ) Network of hospitals has formally welcomed Mountainside Hospital as its newest Clinical Research Affiliate.

12 Aug 2009

FDA approves APP Pharmaceuticals' Idarubicin HCI injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.

10 Aug 2009

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.

6 Aug 2009

Therapeutic hypothermia after cardiac arrest is cost-effective

A brain-preserving cooling treatment called therapeutic hypothermia is a cost-effective way to improve outcomes after out-of-hospital cardiac arrest, which claims the lives of more than 300,000 people each year in the United States and leaves thousands of others neurologically devastated.

6 Aug 2009

Cooling unconscious cardiac arrest survivors increases survival, cost effective

Cooling unconscious cardiac arrest survivors can increase survival and has a cost effectiveness comparable to other widely accepted treatments in modern health care, researchers report in Circulation: Cardiovascular Quality and Outcomes.

4 Aug 2009

Carbon nanosensor sniffs out kidney disease

A carbon nanosensor “electronic nose” - first developed by Technion-Israel Institute of Technology researchers to detect cancer from breath samples - has been modified to identify chronic renal failure (CRF).

4 Aug 2009

'Urine NGAL' gives clues to kidney injury in ICU patients and HIV-related kidney disease

Acute kidney injury (AKI) is a frequent complication in patients in intensive care. A new laboratory test called urine neutrophil gelatinase associated lipocalin (NGAL) helps predict if patients will develop acute kidney injury, reports an upcoming study in the Journal of the American Society of Nephrology (JASN).

26 Jul 2009

Fresh meats often contain additives harmful to kidney disease patients

Uncooked meat products enhanced with food additives may contain high levels of phosphorous and potassium that are not discernable from inspection of food labels, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). This can make it difficult for people to limit dietary phosphorous and potassium that at high levels are harmful to kidney disease patients.

26 Jul 2009

Dialysis treatments OK for patients who have had a heart attack

Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.

9 Jul 2009

Combining two common medical tests provides new way to screen for serious kidney disease

The combination of two common medical tests can improve a doctor's ability to predict which patients will develop serious kidney disease, a research team led by the Norwegian University of Science and Technology (NTNU) reports in a recent issue of the Journal of the American Society of Nephrology.

7 Jul 2009

For America's aged, surgery at any price?

When doctors decide whether or not to go ahead with an expensive surgery, "age is no longer the deciding factor, even for invasive treatment such as open-heart surgery," The Philadelphia Inquirer reports.

7 Jul 2009

1 in 7 Australians over 25 have chronic kidney disease

The latest report from the Australian Institute of Health and Welfare (AIHW) says between 2006 and 2007 more than a million hospital admissions in Australia were due to chronic kidney disease which was also a contributing factor in one in 10 deaths in 2006.

26 May 2009

Overnight dialysis more convenient and effective

Overnight dialysis is more convenient for some patients and offers significant benefits over shorter daytime treatments, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

22 May 2009

Aspirin and an anti-clotting drug ‘combo’ reduces risk of dialysis access failure

For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC).

21 May 2009

Trace elements unbalanced in dialysis patients

Abnormal levels of trace elements may explain dialysis morbidity. A systematic review published in the open access journal BMC Medicine has shown that, compared to healthy controls, dialysis patients have significantly different blood concentrations of trace elements.

18 May 2009

Chemical found in medical devices impairs heart function

Researchers at the Johns Hopkins University School of Medicine have found that a chemical commonly used in the production of such medical plastic devices as intravenous (IV) bags and catheters can impair heart function in rats.

3 May 2009

Change to Medicare reimbursement policy may pose risks to black kidney patients

A change in Medicare reimbursement policy could make it more difficult for African Americans with kidney disease to access dialysis services, suggests a study in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

23 Apr 2009

Knowledge unlocks key to healthier options for dialysis patients

Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

23 Apr 2009

Why do blacks with advanced kidney disease live longer than whites?

Blacks in the United States are more likely to require dialysis and develop end stage renal disease (ESRD) than whites, but they also live longer than whites once they reach later stages of kidney disease.

15 Apr 2009

Hemodialysis patients who fall at greater risk of hospitalizations and mortality

Hemodialysis (HD) patients who fall once or more have a higher risk of hospitalizations and mortality than their sure-footed counterparts, researchers at the University of Virginia Health System have reported.

15 Apr 2009